| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.059 | 0.3 |